000 01270 a2200349 4500
005 20250517055612.0
264 0 _c20161101
008 201611s 0 0 eng d
022 _a1619-7089
024 7 _a10.1007/s00259-015-3213-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTaïeb, David
245 0 0 _aRadiopharmaceuticals in paraganglioma imaging: too many members on board?
_h[electronic resource]
260 _bEuropean journal of nuclear medicine and molecular imaging
_cMar 2016
300 _a391-3 p.
_bdigital
500 _aPublication Type: Editorial
650 0 4 _a3-Iodobenzylguanidine
_xchemistry
650 0 4 _aAlgorithms
650 0 4 _aDiagnostic Imaging
_xmethods
650 0 4 _aFluorodeoxyglucose F18
_xchemistry
650 0 4 _aHumans
650 0 4 _aMutation
650 0 4 _aParaganglioma
_xdiagnostic imaging
650 0 4 _aPhenotype
650 0 4 _aPositron-Emission Tomography
650 0 4 _aRadiopharmaceuticals
_xchemistry
650 0 4 _aSuccinate Dehydrogenase
_xgenetics
700 1 _aHicks, Rodney J
700 1 _aPacak, Karel
773 0 _tEuropean journal of nuclear medicine and molecular imaging
_gvol. 43
_gno. 3
_gp. 391-3
856 4 0 _uhttps://doi.org/10.1007/s00259-015-3213-4
_zAvailable from publisher's website
999 _c25346447
_d25346447